Mar 22 |
Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
|
Mar 19 |
Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK
|
Feb 22 |
Novo to face Wegovy competition in India as local versions loom: Reuters
|
Feb 22 |
Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand
|
Feb 5 |
Why Doctor Reddy's (RDY) is a Top Momentum Stock for the Long-Term
|
Feb 2 |
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
Feb 1 |
Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q3 2024 Earnings Call Transcript
|
Feb 1 |
Dr. Reddy's (RDY) Q3 Earnings and Revenues Surpass Estimates
|
Jan 31 |
Dr. Reddy’s Q3 & 9M FY24 Financial Results
|
Jan 30 |
Dr Reddy's Laboratories Ltd (RDY) Q3 2024 Earnings Call Transcript
|